Description
Glibomet Coated Tablets №40
Ingredients
Glibenclamide and Metformin Hydrochloride.
Mechanism of Action
Glibomet tablets combine the actions of glibenclamide and metformin to improve glycemic control in patients with type 2 diabetes mellitus. Glibenclamide stimulates insulin release from pancreatic beta cells, while metformin reduces hepatic glucose production and enhances insulin sensitivity in peripheral tissues.
Pharmacological Properties
The synergistic effects of glibenclamide and metformin in Glibomet tablets result in improved glucose regulation and insulin sensitivity, contributing to better management of type 2 diabetes mellitus.
Indications for Use
Glibomet tablets are indicated for the treatment of type 2 diabetes mellitus in adults to help control blood sugar levels and manage the condition effectively.
Contraindications
Avoid using Glibomet tablets in patients with type 1 diabetes, diabetic ketoacidosis, severe renal impairment, or known hypersensitivity to sulfonylureas or biguanides due to the potential risks associated with these conditions.
Side Effects
Common side effects of Glibomet may include hypoglycemia, gastrointestinal disturbances, and allergic reactions. It is important to report any adverse effects to your healthcare provider.
Usage Instructions
The recommended dosage of Glibomet is one tablet taken orally once or twice daily with meals. Follow the instructions provided by your healthcare provider and do not exceed the prescribed dose to minimize the risk of adverse effects.
Benefits Compared to Analogues
Glibomet tablets offer the advantage of combining the benefits of glibenclamide and metformin in a single formulation, providing enhanced glycemic control and reduced risk of hypoglycemia compared to using either drug alone.
Suitable Patient Groups
Glibomet tablets are suitable for use in adult patients with type 2 diabetes mellitus who require dual therapy to manage their condition effectively. These tablets may not be suitable for individuals with specific contraindications or medical conditions.
Storage and Shelf Life
Store Glibomet tablets in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the tablets beyond the stated shelf life to ensure optimal efficacy.
Packaging Description
Glibomet tablets are supplied in a package containing 40 coated tablets for oral administration. The packaging is designed to protect the tablets from external factors and maintain their stability until use.
Clinical Evidence and Proven Effectiveness
Glibomet tablets have been evaluated in clinical trials, demonstrating their efficacy in improving glycemic control and reducing the risk of hypoglycemia in patients with type 2 diabetes mellitus. The combination therapy of glibenclamide and metformin in Glibomet has shown superior outcomes compared to monotherapy with either drug alone.
Additional Information
Regular monitoring of blood glucose levels is essential while taking Glibomet tablets to ensure optimal diabetes management. Adherence to a healthy diet and exercise regimen is crucial for maximizing the effectiveness of this medication. Consult your healthcare provider before initiating or modifying your diabetes treatment plan and disclose all medications and supplements you are currently using to prevent potential interactions.
